BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 10789195)

  • 1. [Icodextrin in peritoneal dialysis therapy].
    Grzegorzewska AE; Antczak-Jedrzejczak D
    Przegl Lek; 1999; 56(12):812-6. PubMed ID: 10789195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritonitis occurrence in a multicenter study of icodextrin and glucose in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Dialysis.
    Gokal R; Mistry CD; Peers EM
    Perit Dial Int; 1995; 15(6):226-30. PubMed ID: 7578498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of peritonitis on peritoneal transport characteristics: glucose solution versus polyglucose solution.
    Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
    Kidney Int; 2000 Apr; 57(4):1704-12. PubMed ID: 10760106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled study of icodextrin on the treatment of peritoneal dialysis patients during acute peritonitis.
    Chow KM; Szeto CC; Kwan BC; Pang WF; Ma T; Leung CB; Law MC; Li PK
    Nephrol Dial Transplant; 2014 Jul; 29(7):1438-43. PubMed ID: 24578470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Icodextrin: a review of its use in peritoneal dialysis.
    Frampton JE; Plosker GL
    Drugs; 2003; 63(19):2079-105. PubMed ID: 12962523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between peritoneal permeability and ultrafiltration volume with icodextrin-based peritoneal dialysis solution.
    Moriishi M; Kawanishi H; Watanabe H; Tsuchiya S
    Adv Perit Dial; 2004; 20():166-9. PubMed ID: 15384820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal transport with icodextrin solution.
    Heimbürger O
    Contrib Nephrol; 2006; 150():97-103. PubMed ID: 16720998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Icodextrin as first treatment: reasons to be optimistic].
    Rivera M
    Nefrologia; 2009; 29(2):99-102. PubMed ID: 19396313
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of a dialysis solution with icodextrin on ultrafiltration and selected metabolic parameters in patients treated with peritoneal dialysis].
    Opatrná S; Racek J; Stehlík P; Senft V; Sefrna F; Topolcan O; Opatrný K
    Cas Lek Cesk; 2002 May; 141(9):281-5. PubMed ID: 12061197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Icodextrin and intraperitoneal inflammation.
    Moriishi M; Kawanishi H
    Perit Dial Int; 2008 Jun; 28 Suppl 3():S96-S100. PubMed ID: 18552274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Icodextrin's effects on peritoneal transport.
    Krediet RT; Ho-dac-Pannekeet MM; Imholz AL; Struijk DG
    Perit Dial Int; 1997; 17(1):35-41. PubMed ID: 9068020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of icodextrin to provide adequate ultrafiltration in continuous ambulatory peritoneal dialysis patients.
    Thodis E; Passadakis P; Panagoutsos S; Marinopoulos D; Vargemezis V
    Adv Perit Dial; 1999; 15():171-4. PubMed ID: 10682096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe peritoneal mononucleosis associated with icodextrin use in continuous ambulatory peritoneal dialysis.
    Martín J; Sansone G; Cirugeda A; Sánchez-Tomero JA; Muñoz C; Selgas R
    Adv Perit Dial; 2003; 19():191-4. PubMed ID: 14763060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis.
    Mistry CD; Gokal R; Peers E
    Kidney Int; 1994 Aug; 46(2):496-503. PubMed ID: 7967363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A preceding exchange with polyglucose versus glucose solution modifies peritoneal equilibration test results.
    Lilaj T; Dittrich E; Puttinger H; Schneider B; Haag-Weber M; Hörl WH; Vychytil A
    Am J Kidney Dis; 2001 Jul; 38(1):118-26. PubMed ID: 11431191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glucose polymer in the long dwell exchanges in peritoneal dialysis--advantages and limitations].
    Olszowska A
    Pol Merkur Lekarski; 2008 Apr; 24(142):355-8. PubMed ID: 18634373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal ultrafiltration and serum icodextrin concentration during dialysis with 7.5% icodextrin solution in Japanese patients.
    Ota K; Akiba T; Nakao T; Nakayama M; Maeba T; Park MS; Tranaeus A; Yorioka N;
    Perit Dial Int; 2003; 23(4):356-61. PubMed ID: 12968843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical experience with icodextrin. Multicenter study].
    Guerrero A; Montes R; Martín-Herrera C; Ruiz A; Remón C; Fernández-Ruiz EJ; Pérez-Bañasco V; Benítez M; Martínez-Benavides E; Martínez-González JM; Torán D; Tejuca F; Páez C; del Pino MD
    Nefrologia; 2001; 21(6):574-80. PubMed ID: 11881427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Icodextrin: an alternative peritoneal dialysis fluid.
    Chhabra D; Nash K
    Expert Opin Drug Metab Toxicol; 2008 Nov; 4(11):1455-64. PubMed ID: 18950286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Icodextrine peritoneal dialysis solution in clinical practice].
    Opatrná S
    Vnitr Lek; 2008 Dec; 54(12):1155-60. PubMed ID: 19140524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.